Key Highlights
- Nu-Tek BioSciences to attend CPhI Global 2025 in Frankfurt, which will take place from October 28-30.
- The company is set to highlight 100% animal-free peptones and specialty yeast extracts essential for modern biomanufacturing.
- It focuses on sustainable, scalable solutions supporting pharmaceutical innovation, variability reduction, and global drug development pipelines.
Nu-Tek BioSciences, a leader in animal-free peptones and specialty yeast extracts, has announced its participation at CPhI Global 2025, the world’s largest pharmaceutical industry showcase. The event will take place from October 28–30, 2025, at Messe Frankfurt in Frankfurt, Germany.
Biomanufacturers, researchers, and drug developers attending the event will have the opportunity to see how Nu-Tek’s animal-free solutions streamline production pipelines, reduce variability, and accelerate global pharmaceutical innovation.
Driving Pharma Innovation with Animal-Free Ingredients
Nu-Tek BioSciences’ portfolio includes peptones and yeast extracts that play a vital role in cell culture and industrial fermentation. These two processes are central to the development of vaccines, biologics, and therapeutics. Unlike traditional animal-derived alternatives, the company’s products are manufactured to deliver high consistency, quality, and sustainability.
Each product is produced at Nu-Tek’s state-of-the-art U.S. facility, which holds Organic, HALAL, and Kosher certifications, along with advanced ultrafiltration options. This ensures compliance with stringent regulatory requirements across global markets.
“Our 100% animal-free products are designed to meet the evolving demands of modern biomanufacturing, offering superior performance and helping partners optimize research, development, and production,” said Tom Yezzi, CEO of Nu-Tek BioSciences.
Meeting Industry Leaders at CPhI
At CPhI Global 2025, Nu-Tek will also highlight its Variability Reduction Program, a specialized initiative aimed at improving product reliability and consistency throughout the drug development process. This program is expected to resonate with pharmaceutical innovators looking to reduce risks and improve quality across their pipelines.
Attendees are encouraged to meet with the Nu-Tek team to explore tailored applications and discuss how animal-free peptones can be integrated into their workflows to enhance efficiency and compliance. A full schedule of the company’s CPhI meetings and presentations is available via Nu-Tek CPhI Schedule.
About Nu-Tek BioSciences
Headquartered in Minnetonka, Minnesota, Nu-Tek BioSciences develops and manufactures high-quality animal-origin-free (AOF) peptones and protein hydrolysates. These innovative ingredients are essential for cell culture and microbial fermentation, helping enable the production of vaccines, biologics, and other life-saving medicines.
By focusing on sustainability and scalability, the company supports the future of the global pharmaceutical industry.